Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma

被引:77
作者
Shen, Aidong [1 ]
Zhang, Yunqing [1 ]
Yang, Huiguang [1 ]
Xu, Ruisheng [1 ]
Huang, Guowei [1 ]
机构
[1] Nantong Univ, Sch Med, Jiangyin Peoples Hosp, Dept Orthoped, Jiangyin City 214400, Jiangsu, Peoples R China
关键词
ZEB1; osteosarcoma; RNA interference; EPITHELIAL-MESENCHYMAL TRANSITION; PANCREATIC-CANCER CELLS; E-CADHERIN; BREAST-CANCER; TRANSCRIPTIONAL REPRESSOR; EXPRESSION; EMT; DIFFERENTIATION; ADHESION; ENHANCER;
D O I
10.1002/jso.23012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background This study aimed to investigate the expression of ZEB1 in osteosarcoma tissues and to discuss the relationship between ZEB1 expression and osteosarcoma metastasis. Methods Using RT-PCR and Western blotting, the mRNA and protein expressions of ZEB1 in the osteosarcoma and normal bone tissues were detected. Using the RNA interference technique, the expression of ZEB1 in the human osteosarcoma MG-63 cell line was downregulated, and the changes in the invasion of MG-63 cells were examined. Results The positive mRNA expression rate of ZEB1 in the osteosarcoma tissues was significantly higher than that in normal bone tissue (P?<?0.05). The protein expression level of ZEB1 in the sarcoma tissues from patients with positive lung metastasis was significantly higher than that from patients without lung metastasis (P?<?0.05). After the transfection of ZEB1 siRNA into the MG-63 cells, the protein expression of ZEB1 was significantly reduced (P?<?0.05), and the number of cells that passed through the Transwell chamber was significantly lower than that in the non-transfected control group as well as the transfected control group (P?<?0.05). Conclusions The overexpression of ZEB1 in osteosarcoma may be related to the carcinogenesis and development as well as metastasis and invasion of osteosarcoma. J. Surg. Oncol. 2012; 105:830834. (c) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:830 / 834
页数:5
相关论文
共 41 条
[1]   Inducible expression of TGFβ, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model [J].
Argast, Gretchen M. ;
Krueger, Joseph S. ;
Thomson, Stuart ;
Sujka-Kwok, Isabela ;
Carey, Krista ;
Silva, Stacia ;
O'Connor, Matthew ;
Mercado, Peter ;
Mulford, Iain J. ;
Young, G. David ;
Sennello, Regina ;
Wild, Robert ;
Pachter, Jonathan A. ;
Kan, Julie L. C. ;
Haley, John ;
Rosenfeld-Franklin, Maryland ;
Epstein, David M. .
CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (07) :593-614
[2]   Current treatment of high grade osteosarcoma of the extremity: Review [J].
Bacci, G ;
Lari, S .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (03) :235-243
[3]   RETRACTED: Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells (Retracted article. See vol. 423, pg. 153, 2018) [J].
Bao, Bin ;
Wang, Zhiwei ;
Ali, Shadan ;
Kong, Dejuan ;
Li, Yiwei ;
Ahmad, Aamir ;
Banerjee, Sanjeev ;
Azmi, Asfar S. ;
Miele, Lucio ;
Sarkar, Fazlul H. .
CANCER LETTERS, 2011, 307 (01) :26-36
[4]   Fibre-based post systems: a review [J].
Bateman, G ;
Ricketts, DNJ ;
Saunders, WP .
BRITISH DENTAL JOURNAL, 2003, 195 (01) :43-48
[5]  
DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO
[6]  
2-V
[7]   DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells [J].
Eger, A ;
Aigner, K ;
Sonderegger, S ;
Dampier, B ;
Oehler, S ;
Schreiber, M ;
Berx, G ;
Cano, A ;
Beug, H ;
Foisner, R .
ONCOGENE, 2005, 24 (14) :2375-2385
[8]   The classic: A system for the surgical staging of musculoskeletal sarcoma (Reprinted from Clin Orthop, vol 153, pg 106-120, 1980) [J].
Enneking, WF ;
Spanier, SS ;
Goodman, MA .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2003, (415) :4-18
[9]   Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma [J].
Erdem, Havva ;
Gundogdu, Cemal ;
Sipal, Sare .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2011, 90 (03) :312-317
[10]   Current treatment of osteosarcoma [J].
Ferguson, WS ;
Goorin, AM .
CANCER INVESTIGATION, 2001, 19 (03) :292-315